Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.115709
Revised: January 2, 2026
Accepted: January 22, 2026
Published online: May 27, 2026
Processing time: 215 Days and 13 Hours
Core Tip: Xu et al proposed a bedside nomogram to estimate the probability of multidrug-resistant (MDR) Gram-negative pyogenic liver abscess (PLA) using five routinely available variables. This letter clarifies how such risk stratification can be operationalized at the bedside through concrete clinical scenarios, while arguing that prediction becomes clinically meaningful only when coupled to actionable pathways: Early imaging and source control, rapid resistance-gene testing where available, guideline-concordant empiric coverage in high-risk patients, and stewardship-driven de-escalation. Integrating host vulnerability with pathogen biology may allow hepatology services to move from delayed recognition to prevention-oriented management of MDR-PLA.